Amir Omidvari

Amir Omidvari is a Lecturer at the Rotterdam School of Management (Department of Technology and Operations Management) and a Researcher at Erasmus MC (Public Health Department). His roles involve academic teaching and research in healthcare economics and public health. He specializes in evaluating cost-effectiveness of medical interventions, particularly in cancer screening programs and healthcare policy. His recent work focuses on pancreatic and esophageal cancer screening, digital health innovations, and healthcare cost modeling.

Research interests include cost-effectiveness analysis, medical decision modeling, and public health interventions. Key areas span oncology, healthcare technology, and policy-driven healthcare solutions. His studies often address how screening programs impact life expectancy and healthcare resource allocation.

Recent articles highlight analyses of pancreatic cancer screening efficacy, digital twin applications in healthcare, and comparative cost-effectiveness of endoscopic programs. His collaborative projects involve institutions globally, emphasizing interdisciplinary approaches to disease prevention and treatment optimization. No scientific awards are explicitly mentioned in the provided texts.

No student advisees are listed, and no grant details are provided. His affiliations with Erasmus MC and RSM suggest involvement in academic teams focused on healthcare analytics and technology-driven solutions.